Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CV09070101 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on CV09070101, a putative mRNA vaccine (Jul 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CV09070101 | CV-09070101|CV 09070101|CVHNLC | Limited information is currently available on CV09070101, a putative mRNA vaccine (Jul 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07073183 | Phase I | CV09070101 | Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC) | Not yet recruiting | USA | FRA | ESP | 0 |